Patients with preexisting psychiatric disorders admitted to ICU: a descriptive and retrospective cohort study by unknown
Gacouin et al. Ann. Intensive Care  (2017) 7:1 
DOI 10.1186/s13613-016-0221-x
RESEARCH
Patients with preexisting psychiatric 
disorders admitted to ICU: a descriptive 
and retrospective cohort study
Arnaud Gacouin1,2,3*, Adel Maamar1,2,3, Pierre Fillatre1,2,3, Emmanuelle Sylvestre4,5,6, Margaux Dolan7, 
Yves Le Tulzo1,2,3 and Jean Marc Tadié1,2,3
Abstract 
Background:  While the psychiatric disorders are conditions frequently encountered in hospitalized patients, there 
are little or no data regarding the characteristics and short- and long-term outcomes in patients with preexisting 
psychiatric disorders in ICU. Such assessment may provide the opportunity to determine the respective impact on 
mortality in the ICU and after ICU discharge with reasons for admission, including modalities of self-harm, of underly-
ing psychiatric disorders and prior psychoactive medications.
Methods: ICU and 1-year survival analysis performed on a retrospective cohort of patients with preexisting psychiat-
ric disorders admitted from 2000 through 2013 in a 21-bed polyvalent ICU in a university hospital.
Results: Among the 1751 patients of the cohort, 1280 (73%) were admitted after deliberate self-harm. Psychiat-
ric diagnoses were: schizophrenia, n = 97 (6%); non-schizophrenia psychotic disorder, n = 237 (13%); depression 
disorder, n = 1058 (60%), bipolar disorder, n = 172 (10%), and anxiety disorder, n = 187 (11%). ICU mortality rate was 
significantly lower in patients admitted after self-harm than in patients admitted for other reasons than self-harm 
[38/1288 patients (3%) vs. 53/463 patients (11%), respectively, p < 0.0001]. Compared with patients admitted for delib-
erate self-poisoning with psychoactive medications, patients admitted for self-harm by hanging, drowning, jumping 
from buildings, or corrosive chemicals ingestion had a significantly higher ICU mortality rate. In the ICU, SAPS II score 
[adjusted odds ratio (OR) 1.061, 95% CI 1.041–1.079, p < 0.0001], use of vasopressors (adjusted OR 7.40, 95% CI 2.94–
18.51, p < 0.001), out-of-hospital cardiac arrest (adjusted OR 14.70, 95% CI 3.86–38.51, p < 0.001), and self-harm by 
hanging, drowning, jumping from buildings, or corrosive chemicals ingestion (adjusted OR 11.49, 95% CI 3.76–35.71, 
p < 0.001) were independently associated with mortality. After ICU discharge SAPS II score [adjusted hazard ratio (HR) 
1.023, 95% CI 1.010–1.036, p < 0.01], age (adjusted HR 1.030, 95% CI 1.016–1.044, p < 0.0001), admission for respira-
tory failure (adjusted HR 2.23, 95% CI 1.19–4.57, p = 0.01), and shock (adjusted HR 3.72, 95% CI 1.97–6.62, p < 0.001) 
were independently associated with long-term mortality. Neither psychiatric diagnoses nor psychoactive medications 
received before admission to the ICU were independently associated with mortality.
Conclusions: The study provides data on the short- and long-term outcomes of patients with prepsychiatric disor-
ders admitted to the ICU that may guide decisions when considering ICU admission and discharge in these patients.
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Background
Mental disorders are increasingly involved in prema-
ture mortality as well as years living with a disability 
[1]. Although patients with psychiatric diagnoses are 
common among severely ill patients and may represent 
a significant proportion of those treated in the ICUs [2, 
3], there are no data regarding the epidemiology and 
impact of psychiatric disorders on ICU outcome. The 
largest studies assessing the impact of psychiatric comor-
bidity on outcomes were mostly performed in patients 
with acute myocardial infarction and reported conflict-
ing results [4–6]. Although there are extensive published 
data on the risk of subsequently developing psychiatric 
disorders after an ICU stay [7–10], fewer data on the 
impact of preexisting psychiatric diagnoses on short- and 
long-term ICU outcomes are available [3, 4, 11–13].
Mental disorders cover a large number of varied pathol-
ogies, inducing specific care with specific therapies. For 
instance, a previous study has shown that schizophrenic 
disorders may have a negative impact on outcomes in 
medical ICU [13] and in a large cohort of non-critically ill 
patients with preexisting disorders; Thompson et al. [14] 
have demonstrated that patterns of hospital admission 
for adult psychiatric illness induced dramatic changes in 
patients’ outcome.
Thus, nature of mental disorders, reasons for hospital 
admission, and preexisting medications should be taken 
into account when studying patients with preexisting 
mental disorders in ICU. To our knowledge, the respec-
tive impact of specific psychiatric disorders and reasons 
for admission including self-harm and other reasons for 
admission on short- and long-term outcomes in patients 
with psychiatric disorders admitted to the ICU has not 
been previously assessed in a large population. Such a 
study may help to describe reasons for admission to the 
ICU and assess risk factors for mortality in critically ill 
patients with psychiatric disorders in industrialized 
countries. For that purpose, we performed a retrospec-
tive cohort study on patients with various psychiatric dis-
orders admitted in our ICU from 2000 to 2013.
Methods
Patients and setting
This retrospective study was performed in a mixed 
21-bed ICU admitting mostly medical patients at the 
Rennes University Hospital, a tertiary teaching hospital. 
Patients were identified through: (1) the computerized 
database of the department of intensive care unit (ICU); 
(2) the hospital discharge database from the Program of 
Medicalization of the Information System (PMSI) using 
the International Classification of Diseases, 9th and 10th 
Revisions (ICD-9 and ICD-10). The study was approved 
by the hospital’s ethics committee (No. 14-95), and the 
database was declared to the Commission Nationale de l’ 
Informatique et des Libertés (No. 8274120). We included 
all medical patients aged over 18  years admitted to the 
ICU for the first time between January 1, 2000, and 
December 31, 2013, with at least one of the following psy-
chiatric diagnoses: depressive disorders (ICD 9/10 296.2 
and 296.3; 311; 300.4; F32; F33), anxiety disorders (300–
300.02; 293.84; 309.28; 309.21–309.23; F40 and F41), 
bipolar disorders (296.00–296.06; 296.40–296.89; F30; 
F31), and psychotic disorders including schizophrenia 
(295; F20–F29). Of note, patients with substance depend-
ence (alcohol and/or drug addiction, ICD 9/10 303 and 
304; F10–19) were distinguished from the other patients, 
and their medical records were carefully reviewed for 
these diagnoses [15]. Lastly, despite specific differences, 
underlying psychiatric disorder and self-poisoning some-
times overlap. In the present study, we included only 
patients with known psychiatric diagnoses. Patients were 
excluded when deprived of their liberty, and only the 
first hospitalization was included in the analysis. Follow-
up information was obtained from hospital records and 
when available from the Civil Registration System of the 
city in which patients were born. The outcome was based 
on survival at January 1, 2015, which was used as the end 
of the study period to ensure that all patients had at least 
1 year of observation time.
Data collection and definitions
Data were extracted from medical records through a 
standardized questionnaire. The baseline data collected 
for all patients were: age, sex, and the Simplified Acute 
Physiology Score (SAPS) II calculated within 24  h after 
admission [16]. Patients were distinguished whether 
they were admitted after deliberate self-harm or not, 
and whether they were directly admitted from a psychi-
atric hospital or psychiatric ward or not. Four groups 
of self-harm patients were distinguished: (1) deliberate 
self-poisoning with psychoactive medications alone, (2) 
deliberate self-poisoning with non-psychoactive medica-
tions alone or associated with psychoactive medications, 
(3) deliberate self-poisoning with pesticides, household, 
or industrial products, alone or associated with psycho-
active medications, and (4) deliberate self-harming by 
hanging, drowning, jumping from buildings, or corrosive 
chemicals ingestion alone or associated with psychoac-
tive medications. The following variables recorded upon 
ICU admission and during the ICU stay were: intubation 
and invasive mechanical ventilation, renal replacement 
therapy, vasopressors or inotropic therapy including the 
use of epinephrine, norepinephrine, and dobutamine, 
ICU acquired infections at any sites as defined previously 
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[17], and ICU mortality. In addition, chemical pneu-
monitis and aspiration pneumonia were recorded [18]. 
Regarding the psychoactive medications received by 
patients before admission to the ICU, we considered the 
treatments described in medical records as received reg-
ularly by patients during a minimum of 6  months prior 
to ICU admission. The following psychoactive treat-
ments were recorded: benzodiazepines, neuroleptics, 
antipsychotics other than neuroleptics, lithium, selective 
serotonin reuptake inhibitors (SSRIs), serotonin and nor-
epinephrine reuptake inhibitors (SNRIs), tri- and tetracy-
clics antidepressants, and monoamine oxidase inhibitors 
(MAOIs). Additionally, cause-specific death was assessed 
retrospectively, based on chart abstraction. The proxi-
mate cause of death was defined as the pathology leading 
to the death of the patients or the decision to withhold or 
withdraw intensive care.
Study end points
End points included assessment of general characteris-
tics of patients, reasons for admission to the ICU, iden-
tification of variables independently associated with ICU 
mortality and 1-year mortality after ICU discharge, and 
assessment of proximate causes of death.
Statistical analyses
Data are summarized as number (percentages) for cat-
egorical variables. Quantitative variables are expressed 
as mean  ±  SD if normally distributed and median 
(interquartile range) if non-normally distributed. As 
appropriate, qualitative data were compared using Chi-
square test or Fisher exact test while quantitative data 
were compared using unpaired t test or Mann–Whit-
ney test. We used a logistic regression analysis to iden-
tify variables independently associated with mortality. 
Variables with a P value ≤0.10 in the univariate analysis 
were entered in the model, and results were expressed as 
odds ratios (OR) with their 95% confident interval (CI). 
A univariate Cox regression was used to identify vari-
ables with potential prognostic significance after ICU 
discharge, and the Cox proportional hazards model was 
used to assess the independent contribution of each pre-
dictor. Variables were removed in a backward stepwise 
selection process on the basis of a significance level of 
0.10 in the univariate analysis. Patients who were alive 
at the end of follow-up were censored, and results were 
expressed as hazard ratio (HR) and their 95% (CI). All 
probability values reported are two-sided. Statistical 
analysis was performed with the use of Statistical Pack-
age for Social Sciences, version 17 (SPSS, IBM, Chicago, 




Between January 1, 2000, and December 31, 2013, 13,715 
patients were admitted to the ICU, and 1834 patients 
(13%) with known psychiatric disorders were eligible for 
the study. After reviewing medical records, 91 patients 
were excluded because they had been admitted in the 
ICU before January 2000 (n  =  56) or deprived of their 
liberty (n = 35), and finally, 1743 patients were included 
into the study. Characteristics of patients including diag-
nosed psychiatric disorders, psychoactive treatments, 
and reasons for admissions are listed in Table  1. Rea-
sons for admissions were deliberate self-harm in 1280 
patients (73%) and other than deliberate self-harm in 
463 patients (27%). Among the non-psychoactive medi-
cations recorded in the 139 patients with deliberate self-
poisoning, paracetamol was involved in 49 patients, beta 
blockers in 36 patients, calcium channel blockers in 12 
patients, insulin in 6 patients, chloroquine in 4 patients, 
morphinics in 10 patients. Nineteen patients were admit-
ted after hanging, six patients after drowning, two after 
corrosive chemicals ingestion, one after jumping from 
building, and two after gun shot. Organophosphate pes-
ticides were involved in eight patients, paraquat in two 
patients, strychnine in three patients, ethylene glycol 
in four patients, solvents in three patients, gas in two 
patients.
Mortality in the ICU
ICU mortality rate was significantly lower in patients 
admitted after self-harm than in patients admitted for 
another reason than self-harm [38/1280 patients (3%) vs. 
53/463 patients (11%), respectively, p < 0.0001], and it was 
of 2% in the 1221 patients with deliberate self-poisoning 
with medications only. However, compared with patients 
admitted for deliberate self-poisoning with psychoactive 
medications, patients admitted for self-harm by hang-
ing, drowning, jumping from buildings, or corrosive 
chemicals ingestion had a significantly higher ICU mor-
tality rate. Table  2 shows comparisons between patients 
who survived and those who did not survive their ICU 
stay. Among psychiatric diagnoses recorded, only non-
schizophrenia psychiatric disorder was associated with 
mortality in the univariate analysis. After logistic regres-
sion analysis, SAPS II score (adjusted OR 1.061, 95% CI 
1.041–1.079, p  <  0.0001), use of vasopressors (adjusted 
OR 7.40, 95% CI 2.94–18.51, p  <  0.001), out-of-hospital 
cardiac arrest (adjusted OR 14.70, 95% CI 3.86–38.51, 
p < 0.001), and self-harm by hanging, drowning, jumping 
from buildings, or corrosive chemicals ingestion (adjusted 
OR 11.49, 95% CI 3.76–35.71, p  <  0.001) were indepen-
dently associated with mortality. Neither psychiatric 
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Table 1 Baseline characteristics of the study population
SAPS Simplified Acute Physiology Score, CNS central nervous system, SSRIs selective serotonin reuptake inhibitors, SNRIs selective norepinephrine reuptake inhibitors, 
MAOIs monoamine oxidase inhibitors
Variables Whole population
n = 1743
Age [years (mean ± SD)] 43 ± 3
Male gender [n (%)] 814 (46)
SAPS II score, points (mean ± SD) 34 ± 17
Mental disorder [n (%)]
 Schizophrenia 97 (6)
 Non-schizophrenia psychiatric disorder 237 (13)
 Depression disorder 1058 (60)
 Bipolar disorder 172 (10)
 Anxiety disorder 187 (11)
Substance dependence (alcohol and/or drug addiction) 492 (28)
Transfer from psychiatric hospital or ward [n (%)] 130 (7)
Psychoactive medication before admission [n (%)]
 None 197 (11)
 Benzodiazepines 1043 (60)
 Neuroleptics 497 (28)
 Antipsychotics other than neuroleptics 175 (10)
 Lithium 81 (5)
 SSRIs 420 (24)
 SNRIs 34 (2)
 Tri- or tetracyclics antidepressants 226 (13)
 MAOIs 148 (8)
Admission following deliberate self-harm [n (%)] 1280 (73)
Deliberate self-poisoning with psychoactive medications
 Alone 1082 (62)
 And/or with non-psychoactive medications 139 (8)
 And/or with pesticides, household, or industrial products 28 (1.5)
 And/or with hanging, drowning, jumping from buildings, or corrosive chemicals ingestion 31 (1.5)
Admission for another reason than deliberate self-harm 463 (27)
 Respiratory failure 165 (9)
 Shock 65 (4)
 CNS or peripheral disorder 82 (5)
 Metabolic disorder 53 (3)
 Out-of-hospital cardiac arrest 18 (1)
 Acute kidney injury 13 (0.5)
 Non-deliberate psychoactive medication overdose 44 (2.5)
 Miscellaneous 33 (2)
Chemical pneumonitis and/or aspiration pneumonia [n (%)] 479 (27)
Organ support in the ICU [n (%)]
 Invasive mechanical ventilation 1206 (69)
 Vasopressors 378 (22)
 Renal replacement therapy 176 (10)
ICU outcomes [n (%)]
 Acquired infection at any site 64 (4)
 Mortality 91 (5)
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diagnoses nor psychoactive medications received before 
admission to the ICU were independently associated 
with mortality. Causes of death following self-harm were 
as follows: respiratory (n = 4, 11%), neurological (n = 5, 
13%), out-of hospital cardiac arrest (n = 18, 47%), septic 
shock (n =  1, 3%), cardiogenic shock (n =  6, 15%), and 
fulminans hepatitis (n = 4, 11%). Causes of death in psy-
chiatric patients admitted to ICU for other reasons were 
Table 2 Baseline characteristics and  outcomes compared between  patients who died in  the ICU and  patients who sur-
vived the ICU stay
SAPS Simplified Acute Physiology Score, CNS central nervous system, SSRIs selective serotonin reuptake inhibitors, SNRIs selective norepinephrine reuptake inhibitors, 






Age [years (mean ± SD)] 54 ± 17 45 ± 15 <0.0001
Male gender [n (%)] 46 (51) 766 (46) 0.42
SAPS II score, points (mean ± SD) 69 ± 21 36 ± 15 <0.0001
Mental disorder [n (%)]
 Schizophrenia 3 (3) 94 (6) 0.48
 Non-schizophrenia psychiatric disorder 16 (21) 218 (13) 0.04
 Depression disorder 50 (55) 1008 (60) 0.27
 Bipolar disorder 12 (13) 160 (10) 0.26
 Anxiety disorder 7 (8) 180 (11) 0.48
Substance dependence (alcohol and/or drug addiction) 14 (15) 478 (29) 0.003
Transfer from psychiatric hospital or ward [n (%)] 14 (15) 116 (7) 0.003
Psychoactive medication before admission [n (%)]
 None 9 (10) 189 (11) 0.66
 Benzodiazepines 58 (64) 1138 (68) 0.33
 Neuroleptics 26 (28) 471 (28) 0.97
 Antipsychotics other than neuroleptics 10 (11) 165 (10) 0.74
 Lithium 3 (3) 78 (5) 0.53
 SSRIs 18 (20) 402 (24) 0.33
 SNRIs 1 (1) 33 (2) 0.55
 Tri- or tetracyclics antidepressants 11 (12) 215 (13) 0.81
 MAOIs 8 (9) 140 (8) 0.90
Reason for admission [n (%)]
 Deliberate self-poisoning with psychoactive medications
  Alone 15 (16) 1067 (64) <0.0001
  And/or with non-psychoactive medications 10 (11) 129 (8) 0.27
  And/or with pesticides, household, or industrial products 0 (0) 28 (2) 0.40
  And/or with hanging, drowning, jumping from buildings, or corrosive chemicals ingestion 13 (14) 18 (1) <0.0001
 Respiratory failure 14 (15) 151 (9) 0.06
 Shock 15 (16) 50 (3) <0.0001
 CNS or peripheral disorder 6 (7) 76 (6) 0.31
 Metabolic disorder 1 (1) 52 (3) 0.52
 Out-of-hospital cardiac arrest 14 (15) 4 (0.2) <0.0001
 Acute kidney injury 0 (0) 13 (0.5) 0.99
 Non-deliberate psychoactive medication overdose 2 (2) 42 (2.5) 0.99
 Miscellaneous 3 (3) 30 (2) 0.24
Chemical pneumonitis and/or aspiration pneumonia [n (%)] 28 (31) 451 (27) 0.45
Organ support in the ICU [n (%)]
 Invasive mechanical ventilation 91 (100) 1115 (67) <0.0001
 Vasopressors 84 (92) 294 (18) <0.0001
 Renal replacement therapy 38 (42) 138 (8) <0.0001
Acquired infection at any site 14 (15) 50 (3) <0.0001
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as follows: respiratory (n = 9, 17%), neurological (n = 6, 
11%), out-of-hospital cardiac arrest (n = 13, 24%), septic 
shock (n =  9, 17%), cardiogenic shock (n =  5, 9%), and 
others (n = 11, 20%) (p = 0.03 after comparison).
One‑year mortality after ICU discharge
One hundred thirty-five patients (8%) were lost of view 
within the year following ICU discharge. Results for 
unadjusted and adjusted 1-year survival analysis are 
shown in Table  3. After adjustment, neither psychiatric 
diagnoses nor modalities used for self-harm remained 
independently associated with survival (Table 3). In addi-
tion to age and SAPS II score, admission to the ICU for 
respiratory failure or shock was the variables indepen-
dently associated with prognosis.
Discussion
We performed a retrospective study on a large cohort of 
patients with five psychiatric diagnoses admitted to the 
ICU (i.e., depressive, anxiety, bipolar, and psychotic dis-
orders including schizophrenia). Over a 14-year period, 
this study population represents one in ten patients 
admitted to our ICU over the study period. Depression 
disorder was the most frequent psychiatric disorder 
encountered, and substance dependence was noted in 
28% of these patients. Seventy-five percent of patients 
were admitted after self-harm.
In our study, we found that admissions after self-
harm had a lower mortality rate than admissions for 
other reasons. Although not previously published, these 
results were expected since patients hospitalized for 
self-poisoning are young and often used central nerv-
ous system acting drugs for self-poisoning that required 
intubation during few hours only to protect their airways 
and ensure their ventilation until recovery [2], as found in 
our study: Patients admitted after self-harm were signifi-
cantly younger than the other patients (42 years ± 14 vs. 
55 years ± 15, respectively, p < 0.0001), more frequently 
women (55 vs. 49%, respectively, p  =  0.01), and most 
often used central nervous system acting drugs. Of note, 
deliberate self-harm with hanging, drowning, jumping 
from buildings, or corrosive chemicals ingestion whether 
or not in association with self-poisoning with psychoac-
tive medications was found independently associated with 
ICU mortality. This finding highlights that ICU outcome 
mainly depends on physiologic alterations responsible 
for ICU admission. Along these lines, proximate causes 
of death in the ICU differed between the two groups of 
patients. These characteristics could demonstrate that, 
among patients admitted to the ICU with previously 
known psychiatric disorders, reason for admission should 
be taken into account when considering the real impact of 
psychiatric disorders on ICU mortality.
No study has previously demonstrated that preexisting 
mental disorders were associated with increased mortality 
in ICU. In many diseases such as asthma [19] or chronic 
obstructive pulmonary disease [20, 21], control of the dis-
ease and prognostic are poorer in patients with psychiatric 
comorbidity. These patients could represent a large num-
ber of patients admitted to ICU. For instance, in our study, 
among the 165 patients with respiratory failure as main 
reason for ICU admission, 78 patients (47%) had a his-
tory of chronic obstructive pulmonary disease according 
to the criteria of the American Thoracic Society published 
in 1995 [14] and 11 patients (7%) had a history of obesity 
hypoventilation syndrome. Based on large retrospective 
studies, Abrams et  al. [4] reported that associations with 
the risk of mortality varied among the individual psychi-
atric conditions, depression being the psychiatric disease 
associated with the highest mortality compared to anxi-
ety, psychosis, bipolar disorder, and posttraumatic stress 
disorder. For other authors [6, 22] and mainly in patients 
with acute myocardial infarction, the presence of comor-
bid psychiatric condition is associated with increased 
short-term mortality. The poorer outcome noted here in 
patients admitted for another reason than self-harm may 
be explained in some of them by poor adherence to treat-
ments required by underlying medical condition, admis-
sion to the ICU in late stage of their illness because of 
difficulties in diagnosis [23, 24], or management difficulties 
during the ICU stay [25]. We hypothesize that psychiat-
ric disorders and/or associated psychoactive medications 
could lessen symptoms leading to a delayed research on 
the somatic disease and finally to admission to the ICU 
patients with advanced forms of their disease.
Lastly, chronic psychiatric medication or associated 
substance abuse could induce immunosuppression as 
suggested in several studies and could worsen organ 
dysfunction and increased risk of nosocomial infections 
during ICU stay [14]. Along these lines, immunological 
effects of medications have been evaluated with conflict-
ing results. For instance, it has been shown that both 
haloperidol and quetiapine significantly increased the 
level of IL-4, IL-10 and significantly reduced interferon 
(IFN)-γ production [26] and in  vitro studies on antide-
pressants showed that some antidepressants, such as clo-
mipramine and fluoxetine, more consistently decrease 
pro-inflammatory cytokines [interleukin (IL)-6, IFN-γ, 
tumor necrosis factor (TNF)-α]. Furthermore, the impact 
of mood-stabilizing drugs on cytokine levels remained 
unclear [27–29].
Our study allowed examination of the effect of psycho-
active medications received before admission on short- 
and long-term mortalities, a variable rarely assessed 
despite potential prognostic impact [30]. None of the 
psychoactive medication assessed here and received prior 
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Table 3 Unadjusted and adjusted 4-year prognostic analysis for the 1660 patients who survived the ICU stay
Variable Non adjusted hazard 
ratio
95% Confident interval P value Adjusted hazard ratio 95% Confident interval P value
Age (1-year increment) 1.053 1.041–1.066 <0.0001 1.030 1.016–1.044 <0.0001
Male gender 1.01 0.69–1.46 0.96
SAPS II score (1-point 
increment)
1.037 1.035–1.049 <0.0001 1.023 1.010–1.036 <0.01
Mental disorder
 Anxiety disorder 0.47 0.21–1.07 0.07
 Schizophrenia 1.67 0.87–3.20 0.12




 Depression disorder 0.80 0.55–1.16 0.24
 Bipolar disorder 1.18 0.65–2.14 0.59
Substance depend-
ence (alcohol or drug 
addiction)
1.12 0.79–1.16 0.42
Transfer from psychiatric 
hospital or ward
1.79 1.01–3.19 0.04
Psychoactive medication before admission
 None 1.17 0.72–2.05 0.58
 Benzodiazepines 0.97 0.80–1.90 0.80
 Neuroleptics 1.16 0.78–1.72 0.47
 Antipsychotics other 
than neuroleptics
1.08 0.80–1.47 0.60
 Lithium 1.59 0.77–3.26 0.21
 SSRIs 0.84 0.53–1.32 0.44
 SNRIs 0.34 0.11–1.05 0.48
 Tri- or tetracyclics 
antidepressants
0.52 0.21–1.27 0.52























and/or with hanging, 
drowning, jumping 




 Respiratory failure 3.28 2.11–3.99 <0.0001 2.33 1.19–4.57 0.01
 Shock 6.30 3.76–5.92 <0.0001 3.72 1.97–6.62 <0.001
Page 8 of 9Gacouin et al. Ann. Intensive Care  (2017) 7:1 
to admission to the ICU was found to have a significant 
impact on ICU and long-term outcomes. Unfortunately, 
we were unable to determine whether in the months after 
discharge psychoactive medication use was increased 
in patients who received MV, as previously reported by 
Wunsch et al. [3].
In addition to the retrospective nature of the study, 
some limitations should be addressed. First, we can’t 
exclude uncontrolled confounders or case-mix. Second, 
this is a single-center study, thereby limiting its external 
validity. Third, post-ICU discharge survival could not 
be completed in all patients, which may have influenced 
results, although less than 10% of patients were lost of 
view during the year following ICU discharge. Fourth, 
management of patients after ICU discharge was not 
assessed. Fifth, some may have concern regarding the 
psychiatric diagnoses in critically ill patients [31]. Abrams 
et  al. [4] showed that the number of patients identified 
with psychiatric disorders differ whether inpatient psy-
chiatric diagnosis codes or outpatients codes are used. In 
the present study psychiatric diagnoses were based on in- 
and outpatient data. Patients with bipolar disorder, schiz-
ophrenic and non-schizophrenic psychotic disorders had 
a specialty-confirmed psychiatric diagnosis. On the other 
side, we suspect that many patients were diagnosed and 
treated for depressive or anxiety disorders by general 
practitioners even if patients with a history of suicide 
attempts were evaluated by a psychiatrist before hospi-
tal discharge. The fact that patients with mental illnesses 
are frequently diagnosed without referral to a psychiatrist 
is largely documented [3, 32]. Patients with a depressive 
disorder could be overrepresented, while those with an 
anxiety disorder underrepresented in the present study.
Conclusions
Despite these limitations, we believe that the results of 
the studies provide data on short- and long-term out-
comes in critically ill patients with preexisting psychiatric 
disorders. In addition, our results suggest distinguishing 
patients admitted to the ICU after deliberate self-poison-
ing from the other patients in studies assessing outcomes 
of critically ill patients with preexisting psychiatric dis-
orders. However, none of the psychiatric disorders were 
found independently associated with outcomes, even if 
results of univariate analysis suggest that patients with 
non-schizophrenic disorders and those transferred from 
psychiatric hospital or ward may be at particular high 
risk of poor outcomes. Further studies are needed to con-
firm that preexisting mental disorders are associated with 
poorer outcome in patients admitted to ICU.
SAPS simplified acute physiologic score, CNS central nervous system, SSRIs selective serotonin reuptake inhibitors, SNRIs selective norepinephrine reuptake inhibitors, 
MAOIs monoamine oxidase inhibitors
Table 3 continued
Variable Non adjusted hazard 
ratio
95% Confident interval P value Adjusted hazard ratio 95% Confident interval P value
 CNS or peripheral 
disorder
2.18 1.14–4.17 0.02
 Metabolic disorder 1.50 0.61–3.67 <0.38
 Out-of-hospital cardiac 
arrest
4.52 0.63–7.79 0.13










Organ support in the ICU
 Invasive mechanical 
ventilation
0.84 0.57–1.24 0.38
 Vasopressors 2.01 1.39–3.10 <0.0001




 Acquired infection at 
any site
2.62 1.87–5.37 <0.01
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